Radx tech #2180- ascenciodx -low-cost moderate-throughput covid-19 test to support massive test scaleup at small clinics and community sites
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92022C00005
- Awardee
-
ADL Diagnostics, Inc. UEI UM1UVWN4L5X8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,900,000
Award facts
- Opportunity
-
- 75N92021C00032 Solicitation number
- Contract value 100% obligated
- $14,900,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Woodinville, WA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $14,900,000 |
About this award
ADL Diagnostics, Inc., operating as Anavasi Diagnostics, received a $14.9 million firm fixed-price definitive contract from the National Heart, Lung, and Blood Institute (NHLBI) to develop and deliver a low-cost, moderate-throughput COVID-19 diagnostic test. The contract, awarded November 5, 2021, with a completion date of May 4, 2023, supports the RADX Tech initiative #2180, a federal program designed to rapidly scale up testing capacity for COVID-19 across community-based settings and small clinical facilities. The work will be performed in Woodinville, Washington, and no small business set-aside was utilized for this award.
The RADX (Rapid Acceleration of Diagnostics) Tech program, administered by the NHLBI, was established to accelerate the development and validation of innovative diagnostic solutions to expand national testing capacity during the pandemic. This contract represents part of the federal government's broader effort to support scalable, affordable testing infrastructure at the community level, enabling smaller healthcare providers and clinics to implement diagnostic capabilities without the capital and operational barriers associated with high-complexity laboratory equipment.
Quick answers
Who was awarded contract 75N92022C00005?
75N92022C00005 was awarded to ADL Diagnostics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on November 5, 2021.
How much is contract 75N92022C00005 worth?
The government has obligated $14,900,000 on 75N92022C00005.
Was contract 75N92022C00005 competed?
The extent of competition for 75N92022C00005 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award